OTC · Biotechnology

Oxford BioDynamics Plc (OXBOF) Stock

$0.00 OTC: OXBOF Healthcare

Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise. The company's primary focus lies in the discovery and development of biomarkers for the pharmaceutical and biotechnology industries, serving both domestic and international markets, with a significant presence in the United States.

Valuation

MetricValue
Price$0.00
Market Cap$5.33M
P/E Ratio-0.31
P/B Ratio1.87
P/S Ratio8.98
EPS (TTM)$0.00
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-214.95%
ROA-53.32%
ROCE-131.72%
Gross Margin46.70%
Operating Margin-681.37%
Net Margin-1100.00%
Debt/Equity1.32
Current Ratio2.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$1.0M$1.0M$1.0M
Operating Profit$-8.0M$-9.0M$-10.0M$-13.0M$-11.0M
Net Profit$-7.0M$-7.0M$-11.0M$-12.0M$-11.0M
EPS$-0.07$-0.07$-0.07$-0.04$-0.01
Op Margin-2202.9%-5585.1%-1993.7%-2027.4%-1011.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$15.0M$11.0M$16.0M$12.0M$8.0M
Total Liabilities$9.0M$9.0M$10.0M$8.0M$7.0M
Cash$2.0M$1.0M$5.0M$2.0M$1.0M
Borrowings$7.0M$6.0M$6.0M$6.0M$5.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-6.0M$-5.0M$-8.0M$-10.0M$-8.0M
Investing Cash Flow$0$0$-1.0M$-2.0M$1.0M
Financing Cash Flow$0$0$-1.0M$-1.0M$-1.0M
Net Cash Flow$-4.0M$-1.0M$4.0M$-3.0M$-1.0M
Free Cash Flow$-9.0M$-6.0M$-9.0M$-11.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.50
FCF Yield-274.08%
Quick Ratio1.89
Interest Coverage-32.55
Return 1Y-50.00%
Return 3Y-99.58%
Return 5Y—

Ownership

Insiders Held9.87%
Institutions Held42.97%
Institutions Float Held47.68%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANPCYCelLBxHealth plc $0.07 +0.00% -0.15 $21.98M 0.00%
CHMMFChimeric Therapeutics Limited $0.10 +0.00% -0.06 $4.10M 0.00%
DVHGFDevonian Health Group Inc. $7.00 +0.00% -4.51 $19.47M 0.00%
HOOKHOOKIPA Pharma Inc. $1.15 +0.00% -0.71 $14.40M 0.00%
IMUCEOM Pharmaceuticals Holdings, Inc. $0.25 +90.77% -16.32 $31.37M 0.00%

About Oxford BioDynamics Plc

Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise. The company's primary focus lies in the discovery and development of biomarkers for the pharmaceutical and biotechnology industries, serving both domestic and international markets, with a significant presence in the United States. Central to its operations is EpiSwitch, a proprietary technology platform. This platform facilitates the identification, evaluation, validation, and continuous monitoring of epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These biomarkers are utilized in various applications, including medical testing kits, predicting disease onset or progression, aiding in diagnosis, and informing treatment approaches. Among its innovative products are the EpiSwitch CiRT, a validated prognostic tool for anticipating patient response to checkpoint inhibitor immunotherapy; the EpiSwitch CST, an advanced blood assay designed to forecast the severity of COVID-19 in adult patients; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome profiling and the identification of new biomarkers.

Oxford BioDynamics Plc (OXBOF) stock trades at $0.00 with a market capitalization of $5.33M. The stock is valued at a price-to-earnings (P/E) ratio of -0.31, price-to-book of 1.87, price-to-sales of 8.98. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Oxford BioDynamics Plc generates a return on equity (ROE) of -214.95%, return on capital employed of -131.72%, an operating margin of -681.37%, a net profit margin of -1100.00%.

Official website: www.oxfordbiodynamics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides